Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Skinvisible (SKVI) Shares Outstanding (Weighted Average) (2016 - 2025)

Skinvisible's Shares Outstanding (Weighted Average) history spans 16 years, with the latest figure at $5.4 million for Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) rose 19.03% year-over-year to $5.4 million; the TTM value through Sep 2025 reached $5.4 million, up 19.03%, while the annual FY2024 figure was $5.1 million, 11.49% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2025 was $5.4 million at Skinvisible, roughly flat from $5.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $5.4 million in Q2 2025 and bottomed at $4.5 million in Q2 2021.
  • The 5-year median for Shares Outstanding (Weighted Average) is $4.5 million (2021), against an average of $4.7 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) changed 0.0% in 2021 before it grew 19.03% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $4.5 million in 2021, then changed by 0.0% to $4.5 million in 2022, then changed by 0.0% to $4.5 million in 2023, then increased by 11.49% to $5.1 million in 2024, then grew by 6.77% to $5.4 million in 2025.
  • Per Business Quant, the three most recent readings for SKVI's Shares Outstanding (Weighted Average) are $5.4 million (Q3 2025), $5.4 million (Q2 2025), and $5.4 million (Q1 2025).